Improved versions of our new digital platform for heart failure disease management in China have been developed since April, 2020 rollout.
Novartis researchers aim to preserve kidney function – and quality of life – for patients.
Novartis researchers are using data to accelerate drug development.
These stories offer a glimpse into the lives of people touched by a new era of medicine.
Novartis is investing in a novel type of medicine to reduce the risk of heart disease.
Dr. Theophile Tuyisabe is one of only 18 ophthalmologists in Rwanda. We spoke with him about how he does it.
Explaining Chagas disease through the stories of patients in Latin America.
Lisa, a patient living with CML, shares her experience and discusses the importance of speaking up about unmet needs in your disease.
Alice Shaw, Global Head of Translational Clinical Oncology at Novartis, applies lessons from running clinical trials to the work of designing them.
Novartis is taming nuclear power and putting it to use to treat advanced cancer.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
This site is intended for a global audience.